API Avibactam sodium

Avibactam sodium More Info

1. Chemical Structure and Classification

Avibactam sodium is a β -lactamase inhibitor. Chemically, it has a unique structure that enables it to interact with and inhibit the activity of certain bacterial enzymes. Its molecular formula is C₁₇H₁₆N₃NaO₅S. The structure contains a sulfone moiety and other functional groups that play a crucial role in its inhibitory function.

2. Mechanism of Action

• It works by inactivating β -lactamase enzymes. Bacteria produce these enzymes to break down β -lactam antibiotics like penicillins and cephalosporins. Avibactam sodium binds to the active site of β -lactamases, preventing them from hydrolyzing the β -lactam ring of the antibiotics.
• For example, in the presence of a β -lactam antibiotic and avibactam sodium, the antibiotic can maintain its antibacterial activity against bacteria that would otherwise be resistant due to the production of β -lactamases.

3. Pharmacological Properties

• Absorption : When administered, its absorption characteristics can vary depending on the formulation. For intravenous administration, it enters the bloodstream rapidly and is distributed throughout the body.
• Distribution : It distributes into various body fluids and tissues, reaching the site of infection to exert its inhibitory effect on β -lactamases.
• Metabolism : It undergoes certain metabolic processes in the body. However, the details of its metabolism are still being studied to fully understand its fate in the body.
• Excretion : Excretion occurs mainly through the kidneys. The rate of excretion helps to determine the appropriate dosing intervals to maintain effective drug levels in the body.

4. Therapeutic Uses

• Avibactam sodium is used in combination with other antibiotics, usually β -lactam antibiotics. For example, the combination of ceftazidime - avibactam is used to treat a variety of bacterial infections, including complicated intra - abdominal infections, complicated urinary tract infections caused by certain multidrug - resistant Gram - negative bacteria such as Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii.

5. Resistance and Considerations

• There is a concern about the development of resistance to avibactam sodium. Bacteria may develop mutations that lead to reduced binding of avibactam to β -lactamases or find alternative mechanisms to overcome the inhibitory effect.

Healthcare providers need to use it judiciously, following appropriate guidelines for antibiotic use to minimize the development of resistance and ensure its long - term efficacy.